Endometrial Ablation with a New Thermal Balloon System

Mangeshikar, Prashant; Kapur, Anupam; Yackel, Douglass B.

doi:10.1016/s1074-3804(05)60230-7

Cited by 17 publications

(8 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following Thermablate treatment only one woman reported persistent mild dysmenorrhea. The overall satisfaction rate was 94% (15 of 16 women) with 11 women being very satisfied and 5 women satisfied [4]. Patient profiles were similar to those of other ablation studies.…”

Section: Study In Bombay Indiasupporting

confidence: 75%

Thermablate EAS: a new endometrial ablation system

Yackel¹,

Vilos

2004

Gynecol Surg

Self Cite

View full text Add to dashboard Cite

Objective: To report on Thermablate EAS, the newest endometrial thermal balloon ablation system now available. Design: Thermablate EAS consists of a lightweight reusable hand-held treatment control unit (TCU) with a single use disposable catheter-balloon-cartridge system. Treatment time is <2.5 min. A 6.0-mm diameter catheter allows it to be used in an office or outpatient setting utilizing minimal anesthesia/analgesia. Results: Six-month follow-up data obtained under a Special Access Program for Health Canada in a series of 54 patients showed amenorrhea 20%, spotting 20%, hypomenorrhea 37%, eumenorrhea 16%, and persisting menorrhagia 6%. Conclusion: Thermablate EAS is the smallest, most portable, and simplest endometrial ablation presently available. High rates of clinical success and patient satisfaction combined with enthusiastic acceptance by clinicians of this compact device makes it a very attractive endometrial ablation system.

show abstract

Section: Study In Bombay Indiasupporting

confidence: 75%

Thermablate EAS: a new endometrial ablation system

Yackel¹,

Vilos

2004

Gynecol Surg

Self Cite

View full text Add to dashboard Cite

show abstract

“…Tissue necrosis to a uniform depth of 4–5 mm has been demonstrated. Thermablate has been evaluated by two small studies 31,32 (sample size 16 and 54). Amenorrhoea rates of 25% were reported, with success rates of 80%.…”

Section: Second‐generation Devicesmentioning

confidence: 99%

Current minimal access techniques in the treatment of heavy menstrual bleeding

Justin

Ibraheim

Bagtharia

et al. 2007

The Obstetric & Gynaecologis

View full text Add to dashboard Cite

Key content Heavy menstrual bleeding remains a major problem for some women. Hysterectomy is the leading treatment for this condition but it is recognised to have some serious complications. First‐generation endometrial ablation techniques have a steep learning curve and are carried out under hysteroscopic visualisation. Second‐generation techniques are simpler and have lower complication rates, lower analgesia requirements and potential for outpatient use. Individual assessment is important in deciding the route and method of treatment for heavy menstrual bleeding, taking clinical factors into consideration. Learning objectives To know about the various options currently available for endometrial ablation. To learn about the clinical application, advantages and limitations of various methods of endometrial ablation. To be able to make an informed choice when deciding which modality to use. Ethical issues Intense competition will continue to drive device manufacturers to make claims of effectiveness based on poor‐quality evidence. All users have a responsibility to be well informed and to offer evidence‐based advice to women. Please cite this article as: Justin W, Ibraheim M, Bagtharia S, Haloob R. Current minimal access techniques in the treatment of heavy menstrual bleeding. The Obstetrician & Gynaecologist 2007;9:223–232.

show abstract

“…There is only one available cohort study with a small sample size of 16 patients with results reported at 6 months. 80 Amenorhea was experienced by half the patients and 15 of 16 were satisfied with the results. There have been a number of other presentations of data related to this device but most still have not been published.…”

Section: Thermablatementioning

confidence: 91%

Endometrial Ablation: Where Have We Been? Where Are We Going?

Munro

2006

Clinical Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

Endometrial ablation (EA) is targeted destruction of the endothelial surface of the uterine cavity. The procedure was originally designed as a less invasive alternative to hysterectomy for the symptom of heavy menstrual bleeding unrelated to structural pathology of the uterus, that was not responsive to medical therapy. More recently it has become apparent that the procedure can be performed in the presence of submucous leiomyomas, providing they meet a number of size and location criteria. The first EA serie as published in Germany in the 1930s, but the procedure did not attract much attention until the latter part of the 20th century. Currently, EA can be performed under endoscopic direction with the neodymium:yttrium alumnum garnet laser, with a radiofrequency resectoscope, or with an expanding array of nonresectoscopic EA systems. It is apparent that most but not all of the complications associated with resectoscopic endometrial ablation are eliminated with nonresectoscopic endometrial ablation, but serious morbidity has been reported with all of the newer systems to date. Success and patient satisfaction seem to be enduring in the majority of well-selected patients treated in clinical trials, but repeat surgery, usually hysterectomy, is performed in 25% to 40% by 5 years after surgery. Increased efficiencies should be realized if the procedure could be moved to an office setting.

show abstract

Endometrial Ablation with a New Thermal Balloon System

Cited by 17 publications

References 17 publications

Thermablate EAS: a new endometrial ablation system

Thermablate EAS: a new endometrial ablation system

Current minimal access techniques in the treatment of heavy menstrual bleeding

Endometrial Ablation: Where Have We Been? Where Are We Going?

Contact Info

Product

Resources

About